Core Viewpoint - The article highlights the significance of the China Industrial Biotechnology Innovation Forum and Bio-Manufacturing Industry Conference as a vital platform for collaboration and innovation in the field of industrial biotechnology and bio-manufacturing, aiming to enhance the integration of various sectors including production, academia, research, finance, and talent [5][6]. Event Overview - The conference has been successfully held for twelve sessions since its inception in 2007, establishing itself as a prominent event in China's industrial biotechnology and bio-manufacturing sectors [5]. - The forum aims to foster deep integration of innovation chains, industry chains, capital chains, and talent chains to promote high-quality development in synthetic biology and bio-manufacturing [5]. Key Activities - The event will feature the release of the "China Industrial Biotechnology Development White Paper 2025," which attendees can receive in printed form [6][10]. - The conference will include various sub-forums focusing on topics such as AI in bio-manufacturing, autonomous innovation in industrial strains, and green biosynthesis of chemicals [14][15]. Registration Information - Registration fees are structured with different rates for regular and student representatives, with early registration offering lower fees [15]. - The conference will provide meals and materials for registered attendees, while accommodation and travel expenses are to be covered by the participants [15]. Contact Information - The article provides contact details for inquiries related to the conference, including multiple contacts for assistance [19][20][21].

声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 近日，浙江大学衢州研究院与巴斯夫达成战略创新合作，携手共促可持续材料和工艺的发展。 添加微信请备注： 姓名+公司+职务 破解转化难题，聚焦新能源新材料 浙江大学衢州研究院于2018年12月28日揭牌成立，是浙江大学和衢州市共建的校地合作科创机构。 研究院聚焦新材料、新能源等关键核心领域开展技术创新与成果转化，打造高端化学品概念验证中心与共享型中试平台，构建贯通技术攻关、概念验证、 中试熟化、基金赋能与产业应用的全链条创新体系。 资料来源： --浙江大学衢州研究院 欢迎添加小编微信，加入 合成生物/生物制造/新材料 交流群 此次合作，双方将围绕先进材料、工业生态、分子智造及生物基化学品等重点领域，共同开展关键技术、前沿引领技术及相关标准的协同研发与创新。 楼剑锋（巴斯夫大中华区董事长兼总裁）、任其龙（中国工程院院士、浙江大学衢州研究院院长）代表双方签署战略合作框架协议。 ● 湖南年产5万吨合成生物制造新材料项目开工！以芦苇、秸秆为原料生产可降解高分子材料 ● 投资5000万！ ...

声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 近日，源天生物完成数千万元pre-A++轮融资。 本轮融资由天创资本独家投资，本轮资金将主要用于5000吨产线全面建设与10万吨产线规划布局，加速实现生物酶法再生材料的规模化量产，为公司下 一步发展奠定坚实基础。 资本持续加持：一年内完成三轮融资 作为国内首家实现生物法再生技术商业化落地的公司，自去年8月以来，源天生物在短短一年内已接连完成三轮融资。 生物酶法降解后的PA6单体 近期，源天生物在聚酰胺6（PA6）生物法回收上的取得重要进展。通过生物酶法为PA6材料的循环利用提供了创新解决方案，其温和的反应条件和环保 特性，为纺织、汽车、电子等行业的PA6材料可持续利用提供了新的技术路径。 从去年JHT Homewares CO.,LTD的投资到今年3月获得北洋海棠基金、尚势资本、道彤投资、仁爱集团、利安隆等知名产业投资机构的联合加持再到近期 天创资本的独家投资。每一轮都精准对接源天生物不同发展阶段的需求，既印证了其技术路线的独特价值和发展潜力，也为公司规模化扩张注入了持续动 ...

Core Viewpoint - The article discusses the initiative by the Ministry of Industry and Information Technology and the Ministry of Agriculture and Rural Affairs of China to promote the innovation and development of non-grain bio-based materials, focusing on key technology innovation, application scenario expansion, and the cultivation of characteristic bases [1][4]. Group 1: Recommended Directions - The initiative emphasizes three main directions: key technology innovation, application scenario expansion, and characteristic base cultivation [2][4]. - Key technology innovation focuses on disruptive and leading technologies in areas such as industrial strains and enzyme protein components, non-grain biomass saccharification, and efficient purification of low-concentration products [2][5]. - Application scenario expansion targets the commercialization of bio-based materials in various products like household plastics, engineering plastics, and medical materials, validated in sectors such as logistics, hospitality, and agriculture [2][5]. - Characteristic base cultivation aims to develop industrial bases that effectively address the challenges of collecting and transporting non-grain biomass, contributing positively to regional economic development [2][5]. Group 2: Application Conditions - Eligible applicants include registered production enterprises, research institutions, and industrial parks in China, which must demonstrate sound management and compliance with safety and environmental standards [6]. - The cases submitted should possess high technical standards and complete solutions, with key technologies having independent intellectual property rights and being domestically leading [6]. - Application materials must be objective and truthful, providing real application cases and supporting documents [6]. Group 3: Recommendation Process - The recommendation process involves organizing applications at the provincial level, verifying and recommending cases, and ultimately promoting a selection of significant cases nationwide [6][7]. - Provincial departments will conduct a review of submitted cases and compile a recommendation summary to be sent to the Ministry of Industry and Information Technology [6][7]. - The Ministry will then promote these cases through various media channels and industry events to facilitate knowledge sharing and commercial cooperation [7]. Group 4: Support and Promotion - The initiative includes measures to enhance publicity for recommended cases through mainstream media and industry platforms, fostering experience exchange and collaboration [7]. - Policy support will be provided for the transformation and application of industrial results, including financial backing for relevant enterprises and projects [7]. - Local governments are encouraged to offer additional support for outstanding cases with replicable value, aiding in technology research and product promotion [7].

Core Viewpoint - The article highlights the upcoming Synbio China 2025 event, focusing on the integration of scientists, entrepreneurs, and investors in the field of synthetic biology, emphasizing its strategic importance for the development of China's bio-economy [33]. Event Details - The Synbio China 2025 event will take place on August 1-2, 2025, at the Suzhou International Expo Center, alongside the 7th CMC-China Expo [1]. - Confirmed attendees include experts from various universities such as Beijing University of Chemical Technology, Shanghai Jiao Tong University, and East China University of Science and Technology, as well as representatives from companies like Micro Factory and Henan Biological Industry Group [2]. Agenda Highlights - The agenda includes lectures from academicians and experts, covering topics such as the opportunities and challenges in the industrialization of synthetic biology, and innovative pathways for non-grain biomass potential [6][7]. - Specific sessions will focus on enabling technologies, including enzyme engineering and CRISPR/Cas9 applications, as well as the development of bio-based materials and their industrial applications [8][10]. Industry Challenges - The article discusses the rapid dissemination of synthetic biology concepts in China, while also addressing challenges such as achieving scalable production, realizing the value of synthetic biological products, and fostering innovation in core competitiveness [33]. Networking Opportunities - The event aims to facilitate face-to-face interactions among founders, industry experts, investors, and government representatives, providing a platform for project promotion and industry guidance [35]. Participation and Registration - Attendees are encouraged to register for free through a QR code provided in the article, ensuring access to the event and its networking opportunities [4][12]. Additional Information - The 7th CMC-China Expo is expected to attract around 20,000 participants, featuring 450 exhibiting companies and 600 invited guests, with multiple forums dedicated to cutting-edge topics in the industry [79].

Project Overview - The project involves the establishment of a thousand-ton bio-based product production line, focusing on 1,3-PDO, calcium lactate, vanillin, and sialic acid processing [3] - The total investment for the project is 50 million yuan, with 5 million yuan allocated for environmental protection [3] - The production capacity upon completion will be 720 tons of 1,3-PDO, 940 tons of calcium lactate, 30 tons of vanillin, and 10 tons of sialic acid annually [3] Company Background - Si Peng Bio-materials (Nantong) Co., Ltd. is a wholly-owned subsidiary of Shanghai Si Peng Technology Co., Ltd., established in May 2022 [4] - The company focuses on negative carbon synthetic biology and is led by a team of scientists from Shanghai Jiao Tong University [4] - It has developed a unique one-step method for synthesizing polylactic acid (PLA) from carbon dioxide, achieving a 70% reduction in carbon emissions [4] - The company has partnered with Angel Yeast to establish a thousand-ton production line, with products including bio-based polyols and biodegradable plastics [4] Industry Insights - The bio-based materials sector is witnessing significant developments, with various companies making strides in bio-manufacturing technologies [8] - The market for bio-based materials is projected to grow substantially, indicating a competitive landscape for companies involved in this field [8]

Core Viewpoint - Synthetic biology and biomanufacturing are gaining significant attention and support from various sectors, including government, academia, and industry, highlighting their potential as new productive forces in the economy [1][17]. Event Overview - The SynBio China Third China Synthetic Biology "Scientists + Entrepreneurs + Investors" Expo will be held on August 1-2, 2025, at the Suzhou International Expo Center, featuring over 20,000 participants [3][33]. - The expo will include seven sub-conferences focusing on various aspects of synthetic biology, including health, food, and beauty industries [3]. Industry Challenges - Despite rapid dissemination of synthetic biology concepts in China, the industry faces challenges such as achieving scalable production, realizing product value, market exploration, and innovation in core competitiveness [17]. Applications and Innovations - Synthetic biology is driving innovations in functional ingredients, next-generation food additives, and personalized health foods, showcasing its transformative potential in the food industry [11][12]. - The technology is also advancing in the beauty sector, with applications in functional skincare ingredients and medical aesthetics [15][18]. Collaboration and Networking - The event aims to facilitate collaboration among innovators, industry experts, and investors, providing a platform for project promotion and industry guidance [20].

Core Viewpoint - The successful registration of medical-grade PHA microsphere materials by Zhuhai Maide Biological Technology Co., Ltd. marks a significant advancement in the standardization and regulation of domestic biomedical materials, providing new momentum for the development and industrialization of downstream medical device products [1][5]. Group 1: Main Document Registration - The main document registration system aims to streamline the registration process for medical devices by standardizing the quality data management of key raw materials [2]. - The registration of Maide Biological's medical-grade PHA microspheres will serve as a standardized raw material for Class III absorbable medical devices and drug delivery applications [2]. - Key benefits of the registration include lowering registration barriers, shortening review cycles, and ensuring controllable quality through comprehensive data on the physicochemical properties and biocompatibility of PHA microspheres [2]. Group 2: PHA as a Future Star in Biomedical Materials - Polyhydroxyalkanoates (PHA) are natural polymers synthesized by microorganisms, known for their biodegradability, biocompatibility, and customizable mechanical properties [3]. - PHA degrades into carbon dioxide and water in the body, promoting ATP production and aiding tissue repair, making it an ideal choice for implantable medical devices [3]. - Maide Biological has established a comprehensive technological barrier covering the purification, large-scale production, and end-use applications of medical-grade PHA [3]. Group 3: Core Patent and Production Capacity - The company has developed proprietary purification processes for medical-grade PHA, addressing batch stability issues and has applied for over 50 domestic and international patents [4]. - The production capacity has been upgraded with a thousand-ton production line in Zhanjiang, ensuring a stable supply of industrial-grade PHA and solidifying the supply chain for medical-grade materials [4]. Group 4: Industry Impact - The completion of the main document registration provides a high-standard raw material solution for medical device companies, promoting the independent development of high-end medical materials in China [5]. - Maide Biological aims to break the overseas technology monopoly through innovation, with the large-scale application of PHA microspheres expected to foster a new wave of domestic high-end medical devices in fields such as tumor intervention and aesthetic repair [5].

Core Viewpoint - The establishment of the Marine Biobased Materials Industry Alliance Research Institute represents a significant collaboration between academia and industry, aiming to advance the development of marine biobased materials through shared resources and expertise [3][4]. Group 1: Collaboration and Innovation - The Marine Biobased Materials Industry Alliance Research Institute is a deep collaboration involving universities, enterprises, and research institutions, leveraging academic research and market experience to promote the marine biobased materials industry [3]. - Qingdao University is a leading research institution in marine biobased materials, with significant advancements in polysaccharide fiber technology, providing essential support for the strength, flexibility, and environmental friendliness of seaweed fibers [3]. - Aimer Co., Ltd. has partnered with Qingdao University to optimize the performance of seaweed fibers and has participated in the formulation of national standards for textile analysis [3]. Group 2: Sustainability and Challenges - Marine biobased materials are gaining attention due to their renewable nature and environmental benefits, including natural degradation and reduced reliance on non-renewable resources [4]. - Despite their advantages, the marine biobased materials sector faces challenges such as limited raw material sources, high production costs, and the need for performance improvements [4]. - The establishment of the research institute aims to address these challenges through enhanced collaboration across the industry, contributing to carbon neutrality goals and supporting global sustainable development [4].

Core Viewpoint - Synthetic biology and biomanufacturing have gained significant attention and support from various sectors, including government, academia, and industry, highlighting their importance in driving innovation and economic growth in the biological economy [1][17]. Group 1: Event Overview - The SynBio China Third China Synthetic Biology "Scientists + Entrepreneurs + Investors" Expo will be held on August 1-2, 2025, at the Suzhou International Expo Center [3]. - The expo will feature seven sub-conferences, including discussions on synthetic biology applications in health, food, and cosmetics [3][11][15]. - The event aims to gather over 20,000 participants, showcasing the growing interest and investment in synthetic biology [3][33]. Group 2: Industry Challenges and Opportunities - Despite rapid concept dissemination, the synthetic biology industry in China faces challenges such as scaling production, realizing product value, and fostering market development [17]. - Synthetic biology is viewed as a key to understanding life and a disruptive technology that can significantly enhance China's biological economy [17]. - The industry is focused on promoting collaboration between research and enterprises to facilitate the translation of scientific achievements into practical applications [17][20]. Group 3: Technological Innovations - Advances in synthetic biology include the development of high-throughput reactors, enzyme catalysis, and microbial drug synthesis, which are crucial for biomanufacturing [8][12][15]. - Innovations in functional ingredients and personalized health foods driven by synthetic biology are expected to reshape the food industry [11][14]. - The application of synthetic biology in cosmetics and medical aesthetics is also being explored, with a focus on bio-synthesized ingredients [15][18].